{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:06:23Z","timestamp":1790006783822,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11095-026-04135-y","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:27:18Z","timestamp":1781728038000},"page":"2811-2827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transdermal Ionic Liquid Gel of Erlotinib for Localized Breast Cancer Therapy"],"prefix":"10.1007","volume":"43","author":[{"given":"Paulami","family":"Datta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oly","family":"Katari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Dhake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-9563","authenticated-orcid":false,"given":"Sanyog","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"4135_CR1","doi-asserted-by":"publisher","unstructured":"Smith BD. Radiation therapy for older women with early breast cancer. In: Hayat MA, editor. Methods Cancer Diagn. Ther. Progn. Dordrecht: Springer Netherlands; 2008. p. 493\u2013506. https:\/\/doi.org\/10.1007\/978-1-4020-8369-3_34.","DOI":"10.1007\/978-1-4020-8369-3_34"},{"key":"4135_CR2","unstructured":"Surgery for Breast Cancer | Breast Cancer Treatment, (n.d.). https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/treatment\/surgery-for-breast-cancer.html (accessed May 12, 2023)."},{"key":"4135_CR3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00280-015-2848-y","volume":"76","author":"O Lee","year":"2015","unstructured":"Lee O, Ivancic D, Allu S, Shidfar A, Kenney K, Helenowski I, et al. Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation. Cancer Chemother Pharmacol. 2015;76:1235\u201346. https:\/\/doi.org\/10.1007\/s00280-015-2848-y.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4135_CR4","unstructured":"Recent progress in drug delivery - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/31867161\/ (accessed May 12, 2023)."},{"key":"4135_CR5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/aic.690210522","volume":"21","author":"AS Michaels","year":"1975","unstructured":"Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and invitro experimental measurement. AIChE J. 1975;21:985\u201396. https:\/\/doi.org\/10.1002\/aic.690210522.","journal-title":"AIChE J"},{"key":"4135_CR6","doi-asserted-by":"publisher","unstructured":"Ng KW, Lau WM. Skin deep: the basics of human skin structure and drug penetration. In: Dragicevic N, Maibach HI, editors. Percutaneous Penetration Enhanc. Chem. Methods Penetration Enhanc. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. p. 3\u201311. https:\/\/doi.org\/10.1007\/978-3-662-45013-0_1.","DOI":"10.1007\/978-3-662-45013-0_1"},{"key":"4135_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10549-008-0055-9","volume":"115","author":"MN Dickler","year":"2009","unstructured":"Dickler MN, Cobleigh MA, Miller KD, Klein PM, Winer EP. Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer. Breast Cancer Res Treat. 2009;115:115\u201321. https:\/\/doi.org\/10.1007\/s10549-008-0055-9.","journal-title":"Breast Cancer Res Treat"},{"key":"4135_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/er.13.1.3","volume":"13","author":"JG Klijn","year":"1992","unstructured":"Klijn JG. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev. 1992;13:3\u201317. https:\/\/doi.org\/10.1210\/er.13.1.3.","journal-title":"Endocr Rev"},{"key":"4135_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jconrel.2016.08.036","volume":"239","author":"M Herbrink","year":"2016","unstructured":"Herbrink M, Schellens JHM, Beijnen JH, Nuijen B. Inherent formulation issues of kinase inhibitors. J Control Release. 2016;239:118\u201327. https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.036.","journal-title":"J Control Release"},{"key":"4135_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0973-6883(11)60112-6","volume":"1","author":"AK Arora","year":"2011","unstructured":"Arora AK. Erlotinib-induced hepatotoxicity\u2014clinical presentation and successful management: a case report. J Clin Exp Hepatol. 2011;1:38\u201340. https:\/\/doi.org\/10.1016\/S0973-6883(11)60112-6.","journal-title":"J Clin Exp Hepatol"},{"key":"4135_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.inoche.2024.112114","volume":"161","author":"M Pourmadadi","year":"2024","unstructured":"Pourmadadi M, Mohammadzadeh V, Poorkhalili P, Afjoul N, Behzadmehr R, Fathi-Karkan S, et al. Advances in erlotinib delivery systems: addressing challenges and exploring opportunities in EGFR-targeted cancer therapies. Inorg Chem Commun. 2024;161:112114. https:\/\/doi.org\/10.1016\/j.inoche.2024.112114.","journal-title":"Inorg Chem Commun"},{"key":"4135_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041179","volume":"15","author":"RM Moshikur","year":"2023","unstructured":"Moshikur RM, Carrier RL, Moniruzzaman M, Goto M. Recent advances in biocompatible ionic liquids in drug formulation and delivery. Pharmaceutics. 2023;15:1179. https:\/\/doi.org\/10.3390\/pharmaceutics15041179.","journal-title":"Pharmaceutics"},{"key":"4135_CR13","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1039\/B921462N","volume":"12","author":"K Ueno","year":"2010","unstructured":"Ueno K, Tokuda H, Watanabe M. Ionicity in ionic liquids: correlation with ionic structure and physicochemical properties. Phys Chem Chem Phys. 2010;12:1649\u201358. https:\/\/doi.org\/10.1039\/B921462N.","journal-title":"Phys Chem Chem Phys"},{"key":"4135_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-4365-1","volume-title":"Application of Ionic Liquids in Drug Delivery","year":"2021","unstructured":"Goto M, Moniruzzaman M, editors. Application of Ionic Liquids in Drug Delivery. Singapore: Springer Singapore; 2021. https:\/\/doi.org\/10.1007\/978-981-16-4365-1."},{"key":"4135_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1815526115","author":"A Banerjee","year":"2018","unstructured":"Banerjee A, Ibsen K, Brown T, Chen R, Agatemor C, Mitragotri S. Reply to Rogers and Gurau: definitions of ionic liquids and deep eutectic solvents. Proc Natl Acad Sci U S A. 2018. https:\/\/doi.org\/10.1073\/pnas.1815526115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4135_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/pharmaceutics13040540","volume":"13","author":"R Boscariol","year":"2021","unstructured":"Boscariol R, Caetano \u00c9A, Silva EC, Oliveira TJ, Rosa-Castro RM, Vila MMDC, et al. Performance of Choline Geranate Deep Eutectic Solvent as Transdermal Permeation Enhancer: An In Vitro Skin Histological Study. Pharmaceutics. 2021;13:540. https:\/\/doi.org\/10.3390\/pharmaceutics13040540.","journal-title":"Pharmaceutics"},{"key":"4135_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2024.143252","volume":"364","author":"M El Mohamad","year":"2024","unstructured":"El Mohamad M, Han Q, Dyett B, Yu H, Edgecomb S, Pride MC, et al. Cytotoxicity and cell membrane interactions of choline-based ionic liquids: comparing amino acids, acetate, and geranate anions. Chemosphere. 2024;364:143252. https:\/\/doi.org\/10.1016\/j.chemosphere.2024.143252.","journal-title":"Chemosphere"},{"key":"4135_CR18","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1021\/acs.molpharmaceut.5c00255","volume":"22","author":"D Datta","year":"2025","unstructured":"Datta D, Bandi SP, Venuganti VVK. Influence of choline-based ionogel on transdermal delivery of vancomycin hydrochloride. Mol Pharm. 2025;22:3331\u201350. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00255.","journal-title":"Mol Pharm"},{"key":"4135_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molliq.2019.01.063","volume":"278","author":"RM Moshikur","year":"2019","unstructured":"Moshikur RM, Chowdhury MR, Wakabayashi R, Tahara Y, Moniruzzaman M, Goto M. Ionic liquids with methotrexate moieties as a potential anticancer prodrug: synthesis, characterization and solubility evaluation. J Mol Liq. 2019;278:226\u201333. https:\/\/doi.org\/10.1016\/j.molliq.2019.01.063.","journal-title":"J Mol Liq"},{"key":"4135_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001455","volume":"10","author":"Y Shi","year":"2021","unstructured":"Shi Y, Zhao Z, Peng K, Gao Y, Wu D, Kim J, et al. Enhancement of anticancer efficacy and tumor penetration of sorafenib by ionic liquids. Adv Healthc Mater. 2021;10:e2001455. https:\/\/doi.org\/10.1002\/adhm.202001455.","journal-title":"Adv Healthc Mater"},{"key":"4135_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2024.125841","volume":"412","author":"S Bhamble","year":"2024","unstructured":"Bhamble S, Dighe S, Katari O, Yadav V, Ansari MM, Jain S. Ionic liquid-based ionogel: a novel strategy to improve dermal delivery and in vivo efficacy of etodolac in rheumatoid arthritis management. J Mol Liq. 2024;412:125841. https:\/\/doi.org\/10.1016\/j.molliq.2024.125841.","journal-title":"J Mol Liq"},{"key":"4135_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21608\/ajps.2023.332165","volume":"68","author":"S Osman","year":"2023","unstructured":"Osman S, Yaseen A, Mohammed A. Formulation and characterization of different topical hydrogels loaded with sildenafil citrate. Al-Azhar J Pharm Sci. 2023;68:28\u201342. https:\/\/doi.org\/10.21608\/ajps.2023.332165.","journal-title":"Al-Azhar J Pharm Sci"},{"key":"4135_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1517\/17425247.2014.914027","volume":"11","author":"A Ahad","year":"2014","unstructured":"Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats. Expert Opin Drug Deliv. 2014;11:1149\u201362. https:\/\/doi.org\/10.1517\/17425247.2014.914027.","journal-title":"Expert Opin Drug Deliv"},{"key":"4135_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-021-00445-z","author":"ZT Marlowe","year":"2021","unstructured":"Marlowe ZT, Cavet ME, Coffey MJ. Dose uniformity of loteprednol etabonate (submicron) ophthalmic gel 0.38% compared with prednisolone acetate ophthalmic suspension 1.0%. Invest Ophthalmol Vis Sci. 2021. https:\/\/doi.org\/10.1007\/s40123-021-00445-z.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4135_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.22270\/jddt.v8i2.1564","volume":"8","author":"M Pokharana","year":"2018","unstructured":"Pokharana M, Vaishnav R, Goyal A, Shrivastava A. Stability testing guidelines of pharmaceutical products. J Drug Deliv Ther. 2018;8:169\u201375. https:\/\/doi.org\/10.22270\/jddt.v8i2.1564.","journal-title":"J Drug Deliv Ther"},{"key":"4135_CR26","unstructured":"Singh MP, Nagori BP, Shaw NR, Tiwari M, Jhanwar B. Formulation Development & Evaluation of Topical Gel Formulations Using Different Gelling Agents and Its Comparison with Marketed Gel Formulation, in: 2013. https:\/\/www.semanticscholar.org\/paper\/Formulation-Development-%26-Evaluation-of-Topical-Gel-Singh-Nagori\/d30d885799fb39dd78b678fb8d8c5b56069352c5 (accessed November 25, 2024)."},{"key":"4135_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/nano12010007","volume":"12","author":"A J\u00falio","year":"2021","unstructured":"J\u00falio A, Costa JG, Pereira-Leite C. TransfersomILs: from ionic liquids to a new class of nanovesicular systems. Nanomaterials (Basel). 2021;12:7. https:\/\/doi.org\/10.3390\/nano12010007.","journal-title":"Nanomaterials (Basel)"},{"key":"4135_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.lfs.2013.01.005","volume":"92","author":"S Khurana","year":"2013","unstructured":"Khurana S, Jain NK, Bedi PMS. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci. 2013;92:383\u201392. https:\/\/doi.org\/10.1016\/j.lfs.2013.01.005.","journal-title":"Life Sci"},{"key":"4135_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040578","volume":"16","author":"EM Mohamed","year":"2023","unstructured":"Mohamed EM, Dharani S, Khuroo T, Hamed R, Khan MA, Rahman Z. In vitro and in vivo characterization of the transdermal gel formulation of desloratadine for prevention of obesity and metabolic syndrome. Pharmaceuticals (Basel). 2023;16:578. https:\/\/doi.org\/10.3390\/ph16040578.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4135_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102355","volume":"62","author":"S Chaturvedi","year":"2021","unstructured":"Chaturvedi S, Garg A. An insight of techniques for the assessment of permeation flux across the skin for optimization of topical and transdermal drug delivery systems. J Drug Deliv Sci Technol. 2021;62:102355. https:\/\/doi.org\/10.1016\/j.jddst.2021.102355.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4135_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0378-5173(98)00383-4","volume":"179","author":"J Jaiswal","year":"1999","unstructured":"Jaiswal J, Poduri R, Panchagnula R. Transdermal delivery of naloxone: ex vivo permeation studies. Int J Pharm. 1999;179:129\u201334. https:\/\/doi.org\/10.1016\/S0378-5173(98)00383-4.","journal-title":"Int J Pharm"},{"key":"4135_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124890","volume":"667","author":"T Date","year":"2024","unstructured":"Date T, Katari O, Kuche K, Chaudhari D, Jain S. Launching triple-hit chemo attack on TNBC through nanoparticle-mediated codelivery of cisplatin-chlorambucil conjugate and venetoclax. Int J Pharm. 2024;667:124890. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124890.","journal-title":"Int J Pharm"},{"key":"4135_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/fft2.44","volume":"1","author":"S Kamiloglu","year":"2020","unstructured":"Kamiloglu S, Sari G, Ozdal T, Capanoglu E. Guidelines for cell viability assays. Food Front. 2020;1:332\u201349. https:\/\/doi.org\/10.1002\/fft2.44.","journal-title":"Food Front"},{"key":"4135_CR34","unstructured":"Annexin V_PI.pdf, (n.d.). https:\/\/www.kumc.edu\/Documents\/flow\/Annexin%20V_PI.pdf (accessed November 25, 2024)."},{"key":"4135_CR35","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.2147\/DDDT.S149814","volume":"11","author":"Y Ding","year":"2017","unstructured":"Ding Y, Cui W, Sun D, Wang G-L, Hei Y, Meng S, et al. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB\/c nude mice bearing human breast tumors. Drug Des Devel Ther. 2017;11:3105\u201317. https:\/\/doi.org\/10.2147\/DDDT.S149814.","journal-title":"Drug Des Devel Ther"},{"key":"4135_CR36","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1021\/acs.molpharmaceut.0c00211","volume":"17","author":"M Bathara","year":"2020","unstructured":"Bathara M, Date T, Chaudhari D, Ghadi R, Kuche K, Jain S. Exploring the promising potential of high permeation vesicle-mediated localized transdermal delivery of docetaxel in breast cancer to overcome the limitations of systemic chemotherapy. Mol Pharm. 2020;17:2473\u201386. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00211.","journal-title":"Mol Pharm"},{"key":"4135_CR37","doi-asserted-by":"publisher","unstructured":"OECD, Test No. 402: Acute Dermal Toxicity, OECD, 2017. https:\/\/doi.org\/10.1787\/9789264070585-en.","DOI":"10.1787\/9789264070585-en"},{"key":"4135_CR38","doi-asserted-by":"publisher","unstructured":"OECD, Test No. 404: Acute Dermal Irritation\/Corrosion, OECD, 2015. https:\/\/doi.org\/10.1787\/9789264242678-en.","DOI":"10.1787\/9789264242678-en"},{"key":"4135_CR39","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.jid.2018.09.001","volume":"138","author":"H Alexander","year":"2018","unstructured":"Alexander H, Brown S, Danby S, Flohr C. Research techniques made simple: transepidermal water loss measurement as a research tool. J Invest Dermatol. 2018;138:2295\u2013300. https:\/\/doi.org\/10.1016\/j.jid.2018.09.001.","journal-title":"J Invest Dermatol"},{"key":"4135_CR40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ame2.12139","volume":"3","author":"G Silva-Santana","year":"2020","unstructured":"Silva-Santana G, Bax JC, Fernandes DCS, Bacellar DTL, Hooper C, Dias AASO, et al. Clinical hematological and biochemical parameters in Swiss, BALB\/c, C57BL\/6 and B6D2F1 Mus musculus. Anim Models Exp Med. 2020;3:304\u201315. https:\/\/doi.org\/10.1002\/ame2.12139.","journal-title":"Anim Models Exp Med"},{"key":"4135_CR41","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1039\/C5CC10120D","volume":"52","author":"K Dong","year":"2016","unstructured":"Dong K, Zhang S, Wang J. Understanding the hydrogen bonds in ionic liquids and their roles in properties and reactions. Chem Commun (Camb). 2016;52:6744\u201364. https:\/\/doi.org\/10.1039\/C5CC10120D.","journal-title":"Chem Commun (Camb)"},{"key":"4135_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jconrel.2024.10.034","volume":"376","author":"S Mitragotri","year":"2024","unstructured":"Mitragotri S. Choline geranate (CAGE): a multifaceted ionic liquid for drug delivery. J Control Release. 2024;376:593\u2013600. https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.034.","journal-title":"J Control Release"},{"key":"4135_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1134\/S1061933X24600453","volume":"86","author":"SYu Kottsov","year":"2024","unstructured":"Kottsov SYu, Badulina AO, Trufanova EA, Taran GS, Baranchikov AE, Nelyubin AV, et al. Stability of Ionogels upon Contact with Water: Effect of Polymer Matrix Hydrophobicity and Ionic Liquid Solubility. Colloid J. 2024;86:705\u201318. https:\/\/doi.org\/10.1134\/S1061933X24600453.","journal-title":"Colloid J"},{"key":"4135_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121082","volume":"608","author":"Q Tian","year":"2021","unstructured":"Tian Q, Quan P, Fang L, Xu H, Liu C. A molecular mechanism investigation of the transdermal\/topical absorption classification system on the basis of drug skin permeation and skin retention. Int J Pharm. 2021;608:121082. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121082.","journal-title":"Int J Pharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04135-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:47:25Z","timestamp":1790005645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04135-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4135"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04135-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}